Skip to main content
. 2016 Dec 21;8(6):9354–9365. doi: 10.18632/oncotarget.14069

Table 7. Detailed clinical information of patients in our study.

Categories Numbers
Overall survival 14 months, range (1.75–30.00)
Age 62 years, range (31–78)
Gender Male 63
Female 31
Tumor site Head, neck 48
Body, tail 45
T stage T1+T2 20
T3+T4 73
N stage N0 (negative) 40
N1 (positive) 53
Metastasis M0 (absent) 89
M1 (present) 4
Differentiation G1 10
G2 51
G3 33
Vascular invasion No 81
Yes 12
Nervous invasion No 28
Yes 65